Healthcare AI growth Ilumivu combines behavior-change psychology with real-time data from smartphones and wearables to deliver just-in-time adaptive interventions, indicating a strong opportunity to cross-sell expanded digital health analytics and decision support capabilities to health systems seeking AI-enabled patient care

Acquisition leverage The acquisition of Cardiogram and the integration of its neural network for cardiovascular monitoring creates a compelling case to pursue partnerships with wearables ecosystems, EHR vendors, and hospital networks focusing on proactive cardiovascular risk management

Research-ready platform With a history of supporting healthcare research across numerous diseases at over 100 universities and health systems, there is a clear path to propose tied funding, research collaborations, and sponsored studies using ilumivu’s platform to expand evidence generation and publication potential

Funding momentum Recent funding from Pisgah Fund in 2022 signals investor confidence and potential for growth capital; sales teams can leverage this momentum to secure enterprise pilots, larger contracts, and strategic partnerships with health systems undergoing digital transformation

Mid-market fit Current revenue indicative range and small employee count suggest targeting mid-market healthcare providers, research organizations, and life sciences companies looking for scalable digital health SaaS solutions without the complexity of large enterprise deployments